260 related articles for article (PubMed ID: 11489245)
1. Allogeneic stem-cell transplantation in renal-cell carcinoma.
Hayes-Lattin BM; Maziarz RT; Beer TM
Curr Oncol Rep; 2001 Sep; 3(5):433-7. PubMed ID: 11489245
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
Tykodi SS; Warren EH; Thompson JA; Riddell SR; Childs RW; Otterud BE; Leppert MF; Storb R; Sandmaier BM
Clin Cancer Res; 2004 Dec; 10(23):7799-811. PubMed ID: 15585611
[TBL] [Abstract][Full Text] [Related]
3. Relationship between tumor-infiltrating T lymphocytes and clinical response after reduced-intensity allogeneic hematopoietic stem cell transplantation for advanced renal cell carcinoma: a single center prospective study.
Ishiyama K; Takami A; Suzuki S; Konaka H; Namiki M; Ooi A; Nakao S
Jpn J Clin Oncol; 2009 Dec; 39(12):807-12. PubMed ID: 19770130
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic stem cell transplantation for renal cell carcinoma.
Bregni M; Herr W; Blaise D;
Expert Rev Anticancer Ther; 2011 Jun; 11(6):901-11. PubMed ID: 21707287
[TBL] [Abstract][Full Text] [Related]
5. Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells.
Harlin H; Artz AS; Mahowald M; Rini BI; Zimmerman T; Vogelzang NJ; Gajewski TF
Bone Marrow Transplant; 2004 Mar; 33(5):491-7. PubMed ID: 14716341
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.
Arya M; Chao D; Patel HR
Nat Clin Pract Oncol; 2004 Nov; 1(1):32-8. PubMed ID: 16264797
[TBL] [Abstract][Full Text] [Related]
7. Nonmyeloablative transplantation: an allogeneic-based immunotherapy for renal cell carcinoma.
Takahashi Y; Childs RW
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6353S-9S. PubMed ID: 15448030
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation for renal cell carcinoma.
Childs R; Drachenberg D
Curr Opin Urol; 2001 Sep; 11(5):495-502. PubMed ID: 11493771
[TBL] [Abstract][Full Text] [Related]
9. Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma.
Childs RW
Crit Rev Immunol; 2001; 21(1-3):191-203. PubMed ID: 11642604
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoetic stem cell transplantation for cytokine refractory renal cell carcinoma.
Drachenberg D; Childs RW
Cancer Treat Res; 2003; 116():213-26. PubMed ID: 14650835
[No Abstract] [Full Text] [Related]
11. Long-term graft-versus-tumor effect following reduced intensity hematopoietic stem cell transplantation in a child with metastatic renal cell carcinoma.
Baek HJ; Han DK; Hwang TJ; Bae SH; Choi YD; Kook H
Pediatr Blood Cancer; 2012 Sep; 59(3):583-5. PubMed ID: 22231905
[TBL] [Abstract][Full Text] [Related]
12. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
Childs R; Chernoff A; Contentin N; Bahceci E; Schrump D; Leitman S; Read EJ; Tisdale J; Dunbar C; Linehan WM; Young NS; Barrett AJ
N Engl J Med; 2000 Sep; 343(11):750-8. PubMed ID: 10984562
[TBL] [Abstract][Full Text] [Related]
13. The identification of renal cell carcinoma as a target for allogeneic based cancer immunotherapy.
Childs RW; Igarashi T
Exp Nephrol; 2002; 10(3):227-34. PubMed ID: 12053124
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation as immunotherapy for renal cell carcinoma: from immune enhancement to immune replacement.
Drachenberg D; Childs RW
Urol Clin North Am; 2003 Aug; 30(3):611-22. PubMed ID: 12953759
[TBL] [Abstract][Full Text] [Related]
15. Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.
Takahashi Y; Harashima N; Kajigaya S; Yokoyama H; Cherkasova E; McCoy JP; Hanada K; Mena O; Kurlander R; Tawab A; Srinivasan R; Lundqvist A; Malinzak E; Geller N; Lerman MI; Childs RW
J Clin Invest; 2008 Mar; 118(3):1099-109. PubMed ID: 18292810
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.
Rini BI; Zimmerman T; Stadler WM; Gajewski TF; Vogelzang NJ
J Clin Oncol; 2002 Apr; 20(8):2017-24. PubMed ID: 11956260
[TBL] [Abstract][Full Text] [Related]
17. Nonmyeloablative allogeneic peripheral blood stem-cell transplantation as immunotherapy for malignant diseases.
Childs RW
Cancer J; 2000; 6(3):179-87. PubMed ID: 10882334
[No Abstract] [Full Text] [Related]
18. Allogeneic stem cell transplantation for the treatment of advanced solid tumors.
Bregni M; Bernardi M; Ciceri F; Peccatori J
Springer Semin Immunopathol; 2004 Nov; 26(1-2):95-108. PubMed ID: 15378271
[TBL] [Abstract][Full Text] [Related]
19. Nonmyeloablative allogeneic stem cell transplantation in metastatic renal cell carcinoma: a new therapeutic option or just a clinical experiment?
Roigas J; Massenkeil G
World J Urol; 2005 Jul; 23(3):213-20. PubMed ID: 15685446
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem-cell transplantation for renal-cell cancer.
Gommersall L; Hayne D; Lynch C; Joseph JV; Arya M; Patel HR
Lancet Oncol; 2004 Sep; 5(9):561-7. PubMed ID: 15337486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
